Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Dive
preface
classgrid-row grid-gap
Dive
prefacemobile-lg:
classgrid-col-6

Micrograph of Plasma CellsImage Modified

Span
classcredit

National Library of Medicine.  Learn more about Potter's Olympus Microscope (TODO: Link)

Dive
prefacemobile-lg:
classgrid-col-6

Michael Potter's MicroscopeImage Modified

Span
classcaption

Permanent collection of the NIH Stetten Museum.  Courtesy of Dr. Beverly Mock, NCI

Span
classcredit

National Library of Medicine

...

Potter was usually at his laboratory bench using this microscope. Shown are plasma cells with darkly stained nuclei. The clear spots next to the nucleus are perinuclear “hoffs” and are filled with newly synthesized protein, in this case, antibody.

Retroviruses Oncogene Activation

Potter collaborated with Marshall Sklar and Wallace Rowe of the National Institute of Allergy and Infectious Diseases to see if viruses could affect the growth of Potter’s plasma cell tumors. Although viruses did not cause the tumors, they found that retroviruses containing oncogenes could accelerate tumor growth when injected into mice, and could even induce tumors in normally resistant mice. Grace Shen-Ong, who worked in Potter’s laboratory, and Michael Cole then found that plasma cells that develop tumors have chromosomal translocations involving genes for immunoglobulins and an oncogene called MYC. But Potter — working with J. Frederic Mushinski, Ken Marcu, Rex Risser, and Siegfried Janz — found that these translocations alone did not cause tumors. And retroviruses had to contain both MYC and another oncogene to induce plasma cell tumors.

Illustration showing oncogene activation causing cells to proliferateImage Added

Span
classcredit

Illustration designed by Sayeh Gorjifard, NCI, OD, CCT

Dive
preface
classgrid-row grid-gap
Dive
preface
classgrid-col-8

Potter and Beverly Mock identified genetically inherited alleles of genes that control the susceptibility of BALB/c mice to plasma cell tumor development. Mock performed one of the first genome-wide linkage studies in mice showing that multiple genes are linked to tumor susceptibility. Then they created congenic strains of mice to fine map the genes to specific regions of chromosomes, leading to the identification of two tumor suppressors (p16 and Mndal) and a growth promoting gene (mTOR) as plasma cell tumor susceptibility genes. BALB/c mice carry a rare allele of mTOR. Today, these tumor incidence studies have been used to inform potential drug combination therapies for people with multiple myeloma.

Dive
prefacemobile-lg:
classgrid-col-4

Image Added

Span
classcaption

Beverly Mock, Ph.D., Senior Investigator, Laboratory of Cancer Biology and Genetics, NCI/CCR

Span
classcredit

NCI Collection.  Photo by Bill Branson